lacovim lacosamide 200 mg tablet blister pack
pharmacor pty ltd - lacosamide, quantity: 200 mg - tablet, film coated - excipient ingredients: crospovidone; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; hyprolose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - lacosamide film-coated tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.
lacosacor lacosamide 100 mg tablet bottle
pharmacor pty ltd - lacosamide, quantity: 100 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; colloidal anhydrous silica; magnesium stearate; crospovidone; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - lacosamide film-coated tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.
lacovim lacosamide 150 mg tablet bottle
pharmacor pty ltd - lacosamide, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; hyprolose; crospovidone; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - lacosamide film-coated tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.
cazitel plus tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
cazitel plus xl tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 175,504,525 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
exitel plus tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
exitel plus xl tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 175,504,525 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
milaxyn plus tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
milaxyn plus xl tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 175,504,525 mg/tablet - praziquantel, combinations - dogs - endoparasiticide
wormaway plus tablets for dogs
chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide